On Friday, Lemonade received a positive adjustment to its Relative Strength (RS) Rating, from 87 to 91.
Here Are 3 Keys For Successful Stock Investing
IBD's proprietary RS Rating identifies technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the trailing 52 weeks matches up against the rest of the market.
Over 100 years of market history shows that the market's biggest winners tend to have an RS Rating of at least 80 in the early stages of their moves.
Lemonade is now considered extended and out of buy range after clearing a 24.55 buy point in a second-stage consolidation. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
The company posted 0% EPS growth last quarter. Sales increased 27%.
Lemonade holds the No. 45 rank among its peers in the Insurance-Property/Casualty/Title industry group. Skyward Specialty Ins, Goosehead Insurance Cl A and AXIS Capital Holdings are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
